Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,200 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 August 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 187 pages)

 

Export 28 results:
Author Title [ Type(Desc)] Year
Filters: Author is Becker, C.  [Clear All Filters]
Journal Article
C. Becker, Jick, S. S., and Meier, C. R., ACE inhibitor use and risk of cataract: a case-control analysis, Br J Ophthalmol, 2019.
J. Vavanikunnel, Charlier, S., Becker, C., Schneider, C., Jick, S. S., Meier, C. R., and Meier, C., Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study, J Clin Endocrinol Metab, 2019.
C. Becker, Brobert, G. P., Johansson, S., Jick, S. S., and Meier, C. R., Cancer risk in association with Parkinson disease: a population-based study, Parkinsonism Relat Disord, vol. 16, pp. 186-90, 2010.
C. Becker, Meier, C. R., Jick, S. S., and Bodmer, M., Case-control analysis on metformin and cancer of the esophagus, Cancer Causes Control, vol. 24, pp. 1763-70, 2013.
C. Becker, Schneider, C., Aballea, S., Bailey, C., Bourne, R., Jick, S., and Meier, C., Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors, Eye (Lond), vol. 32, pp. 1028-1035, 2018.
C. Becker, Brobert, G. P., Johansson, S., Jick, S. S., and Meier, C. R., Diabetes in patients with idiopathic Parkinson's disease, Diabetes Care, vol. 31, pp. 1808-12, 2008.
C. Seliger, Meier, C. R., Becker, C., Jick, S. S., Proescholdt, M., Bogdahn, U., Hau, P., and Leitzmann, M. F., Diabetes, use of metformin, and the risk of meningioma, PLoS One, vol. 12, p. e0181089, 2017.
C. Seliger, Meier, C. R., Becker, C., Jick, S. S., Proescholdt, M., Bogdahn, U., Hau, P., and Leitzmann, M. F., Metabolic syndrome in relation to risk of meningioma, Oncotarget, vol. 8, pp. 2284-2292, 2017.
C. Becker, Jick, S. S., Meier, C. R., and Bodmer, M., Metformin and the risk of endometrial cancer: a case-control analysis, Gynecol Oncol, vol. 129, pp. 565-9, 2013.
C. Becker, Jick, S. S., Meier, C. R., and Bodmer, M., Metformin and the risk of head and neck cancer: a case-control analysis, Diabetes Obes Metab, vol. 16, pp. 1148-54, 2014.
C. Becker, Jick, S. S., Meier, C. R., and Bodmer, M., Metformin and the risk of renal cell carcinoma: a case-control analysis, Eur J Cancer Prev, vol. 26, pp. 257-262, 2017.
M. Bodmer, Becker, C., Jick, S. S., and Meier, C. R., Metformin does not alter the risk of lung cancer: a case-control analysis, Lung Cancer, vol. 78, pp. 133-7, 2012.
A. Afonso, Schmiedl, S., Becker, C., Tcherny-Lessenot, S., Primatesta, P., Plana, E., Souverein, P., Wang, Y., Korevaar, J. C., Hasford, J., Reynolds, R., de Groot, M. C., Schlienger, R., Klungel, O., and Rottenkolber, M., A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction, Eur J Clin Pharmacol, vol. 72, pp. 1105-16, 2016.
C. Becker, Brobert, G. P., Almqvist, P. M., Johansson, S., Jick, S. S., and Meier, C. R., Migraine and the risk of stroke, TIA, or death in the UK (CME), Headache, vol. 47, pp. 1374-84, 2007.
C. Becker, Brobert, G. P., Almqvist, P. M., Johansson, S., Jick, S. S., and Meier, C. R., Migraine incidence, comorbidity and health resource utilization in the UK, Cephalalgia, vol. 28, pp. 57-64, 2008.
C. Becker, Jick, S. S., Meier, C. R., and Bodmer, M., No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study, BMC Cancer, vol. 15, p. 719, 2015.
C. Becker, Wilson, J. C., Jick, S. S., and Meier, C. R., Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis, Int J Cancer, vol. 137, pp. 2424-31, 2015.
C. Becker, Jick, S. S., and Meier, C. R., NSAID use and risk of Parkinson disease: a population-based case-control study, Eur J Neurol, vol. 18, pp. 1336-42, 2011.
K. Gruntz, Bloechliger, M., Becker, C., Jick, S. S., Fuhr, P., Meier, C. R., and Ruegg, S., Parkinson disease and the risk of epileptic seizures, Ann Neurol, vol. 83, pp. 363-374, 2018.
C. Becker, Brobert, G. P., Johansson, S., Jick, S. S., and Meier, C. R., Risk of incident depression in patients with Parkinson disease in the UK, Eur J Neurol, vol. 18, pp. 448-53, 2011.
C. Becker, Brobert, G. P., Almqvist, P. M., Johansson, S., Jick, S. S., and Meier, C. R., The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions, Headache, vol. 48, pp. 606-10, 2008.
C. Becker, Jick, S. S., and Meier, C. R., Risk of stroke in patients with idiopathic Parkinson disease, Parkinsonism Relat Disord, vol. 16, pp. 31-5, 2010.
C. Becker, Jick, S. S., and Meier, C. R., Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis, Ophthalmology, vol. 124, pp. 1635-1639, 2017.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis, Am J Gastroenterol, vol. 107, pp. 620-6, 2012.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., Use of metformin and the risk of ovarian cancer: a case-control analysis, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
C. Seliger, Meier, C. R., Becker, C., Jick, S. S., Bogdahn, U., Hau, P., and Leitzmann, M. F., Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma, PLoS One, vol. 11, p. e0149293, 2016.
C. Becker, Jick, S. S., and Meier, C. R., Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK, Drug Saf, vol. 31, pp. 399-407, 2008.
[Page last reviewed 5 August 2019]